July 20, 2020
Test and trace continues
Data demonstrates a huge improvement in turnaround times of test results More than 144,000 people who may have been at … Read More “Test and trace continues”
Category: Practice Operation and Development
July 17, 2020
Patient reviews and health checks
Practices must resume the delivery of face-to-face care ‘where clinically appropriate’, NHS England has confirmed. Elements of QOF reporting are … Read More “Patient reviews and health checks”
July 16, 2020
NHS providers lead digital change
The consequences of taking a technology-centred approach to the uncertain and uncontrollable environment of digital public services can be ruinous. … Read More “NHS providers lead digital change”
July 15, 2020
100 outbreaks tackled a week
Mr Hancock said increased testing meant officials could now be “targeted” in their response. This is at a time when … Read More “100 outbreaks tackled a week”
July 14, 2020
GP Patient Survey 2020
Around one in five patients (21.7%) say they tried to contact an NHS service in the past 12 months when … Read More “GP Patient Survey 2020”
July 13, 2020
Restart of medical tests and fitness to practise work
The GMC has set out its plans for resuming Professional and Linguistic Assessment Board 2 (PLAB 2) tests for overseas … Read More “Restart of medical tests and fitness to practise work”
July 8, 2020
PM’s as partners
After initially announcing that PM’s would be excluded from the new Partnership scheme launched on 1st July, it appears NHS … Read More “PM’s as partners”
July 6, 2020
HEE launches new resource pack
New resources are aimed at easing student doctors into Foundation training and supporting them during the programme. The resources will … Read More “HEE launches new resource pack”
July 3, 2020
Outstanding BAME risk assessments
NHS England has written to GP practices asking them to complete risk assessments for at-risk staff within four weeks. It … Read More “Outstanding BAME risk assessments”
July 2, 2020
NICE guidance does not recommend siponimod
NICE has issued draft guidance for public consultation which does not recommend siponimod for treating secondary progressive multiple sclerosis (MS). … Read More “NICE guidance does not recommend siponimod”